Home / APAF1 Knockout Cell Lines

APAF1 Knockout Cell Lines

Gene: APAF1

Official Full Name: apoptotic peptidase activating factor 1provided by HGNC

Gene Summary: This gene encodes a cytoplasmic protein that initiates apoptosis. This protein contains several copies of the WD-40 domain, a caspase recruitment domain (CARD), and an ATPase domain (NB-ARC). Upon binding cytochrome c and dATP, this protein forms an oligomeric apoptosome. The apoptosome binds and cleaves caspase 9 preproprotein, releasing its mature, activated form. Activated caspase 9 stimulates the subsequent caspase cascade that commits the cell to apoptosis. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO02390 APAF1 Knockout cell line (HeLa) Human APAF1 1:3~1:6 Negative Online Inquiry
KO02391 APAF1 Knockout cell line (HCT 116) Human APAF1 1:2~1:4 Negative Online Inquiry
KO02392 APAF1 Knockout cell line (HEK293) Human APAF1 1:3~1:6 Negative Online Inquiry
KO02393 APAF1 Knockout cell line (A549) Human APAF1 1:3~1:4 Negative Online Inquiry

Background

APAF1 Gene Knockout Cell Lines are genetically engineered cellular models designed to study the role of the apoptotic protease activating factor 1 (APAF1) gene in cellular apoptosis and various signaling pathways. By specifically deleting or inactivating the APAF1 gene, these cell lines create a controlled environment for researchers to investigate the implications of impaired apoptotic signaling on cell survival, proliferation, and the development of malignancies.

The key function of the APAF1 Gene Knockout Cell Lines lies in their ability to elucidate the molecular mechanisms of apoptosis, particularly in the context of mitochondrial and cytoplasmic pathways. Without functional APAF1, cells exhibit a robustness against apoptosis, which can be observed through various assays that measure cellular response to stressors, pharmaceuticals, or apoptotic stimuli. This experimental model is essential for understanding how the dysregulation of apoptosis contributes to cancer development and resistance to therapeutic agents.

In terms of scientific importance, these knockout cell lines are invaluable in both research and clinical settings. They allow scientists to dissect the complex interplay between apoptosis and other cellular processes, paving the way for potential therapeutic strategies that target apoptotic pathways. These insights are critical for the development of new anticancer drugs, particularly in enhancing the effectiveness of existing treatments.

The unique selling points of APAF1 Gene Knockout Cell Lines include their specificity and versatility. Unlike alternative models that may confound results with variable gene expressions, these cell lines offer reproducible, consistent outcomes, significantly streamlining experimental design. Their ease of use in high-throughput screening applications makes them an attractive option for researchers focusing on drug development and functional genomics.

For researchers and clinicians striving to advance their understanding of apoptosis-related pathways, these knockout cell lines provide a powerful tool that can drive innovation in therapeutic interventions. As a company dedicated to advancing scientific discovery, we pride ourselves on our expertise in genetic engineering and our commitment to providing high-quality, reliable biological products that facilitate groundbreaking research. Our APAF1 Gene Knockout Cell Lines are at the forefront of this mission, ensuring researchers have access to the best tools available for their studies.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.